A XM não fornece serviços a residentes nos Estados Unidos da América.
Q
Q

QIEN


Notícias

QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays

BRIEF-QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays Sept 26 (Reuters) - Qiagen NV QIA.DE : QIAGEN NV: GETS EUROPEAN IVDR CERTIFICATION FOR QIASTAT-DX SYNDROMIC TESTING INSTRUMENTS AND ASSAYS Source text for Eikon: ID:nGNX5rwY0C Further company coverage: QIA.DE
Q

PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples

BRIEF-PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples Sept 25 (Reuters) - Qiagen NV QIA.DE : PREANALYTIX, A QIAGEN AND BD JOINT VENTURE, LAUNCHES NOVEL SOLUTION FOR LIQUID BIOPSY FROM URINE SAMPLES Source text for Eikon: ID:nGNX3v5zxJ Further company coverage: QIA.DE
Q

Qiagen Bode Technology Would Become Exclusive Global Commercial Partner For GEDmatch Pro Genealogy Database

BRIEF-Qiagen Bode Technology Would Become Exclusive Global Commercial Partner For GEDmatch Pro Genealogy Database Sept 23 (Reuters) - Qiagen NV QIA.DE : QIAGEN NV: BODE TECHNOLOGY WOULD BECOME EXCLUSIVE GLOBAL COMMERCIAL PARTNER FOR GEDMATCH PRO GENEALOGY DATABASE Source text for Eikon: ID:nGNX4Tyd3d Further company coverage: QIA.DE
Q

Qiagen And Bio-Manguinhos/Fiocruz Collaborate To Enhance Malaria And Dengue Detection In Brazil’s National Screening Programs

BRIEF-Qiagen And Bio-Manguinhos/Fiocruz Collaborate To Enhance Malaria And Dengue Detection In Brazil’s National Screening Programs Sept 12 (Reuters) - Qiagen NV QIA.DE : QIAGEN AND BIO-MANGUINHOS/FIOCRUZ COLLABORATE TO ENHANCE MALARIA AND DENGUE DETECTION IN BRAZIL’S NATIONAL SCREENING PROGRAMS Source text for Eikon: ID:nGNX9sbmqF Further comp
Q

QIAGEN And Lilly Collaborate To Support Development Of QIAstat-Dx IVD Panel

BRIEF-QIAGEN And Lilly Collaborate To Support Development Of QIAstat-Dx IVD Panel Sept 5 (Reuters) - QIAGEN NV QIA.DE : SAID ON WEDNESDAY: QIAGEN AND LILLY COLLABORATE TO SUPPORT DEVELOPMENT OF QIASTAT-DX IVD PANEL THAT IDENTIFIES PATIENTS AT RISK FOR DEVELOPING ALZHEIMER’S DISEASE COLLABORATION SET TO LAUNCH FIRST COMMERCIALLY AVAILABLE IVD KIT
Q

Qiagen Announces Successful Placement Of New Net Share Settled Convertible Bonds

BRIEF-Qiagen Announces Successful Placement Of New Net Share Settled Convertible Bonds Sept 3 (Reuters) - QIAGEN NV QIA.DE : ANNOUNCES SUCCESSFUL PLACEMENT OF NEW NET SHARE SETTLED CONVERTIBLE BONDS REFERENCE SHARE PRICE WILL BE EQUAL TO VOLUME WEIGHTED AVERAGE PRICE OF SHARES ON NEW YORK STOCK EXCHANGE TODAY, SEPTEMBER 3, 2024 INITIAL CONVERSION P
Q

Qiagen Launches Non-Us Offering Of Net Share Settled Convertible Bonds

BRIEF-Qiagen Launches Non-Us Offering Of Net Share Settled Convertible Bonds Sept 3 (Reuters) - QIAGEN NV QIA.DE : LAUNCHES NON-US OFFERING OF NET SHARE SETTLED CONVERTIBLE BONDS COMPANY INTENDS TO ISSUE BONDS IN MINIMUM DENOMINATIONS OF USD 200,000 EACH, IN AN AGGREGATE VOLUME OF USD 450 MILLION HAVE RESOLVED TODAY TO ISSUE SENIOR, UNSECURED NET SHARE SETTLED CONVERTIBLE BONDS, WHICH MAY BE CONVERTED IN PART INTO ORDINARY SHARES OF COMPANY ("SHARES"), DUE 2031 ( " BONDS").
Q

Admiral Group, IAG, Keller Group

EUROPE RESEARCH ROUNDUP- Admiral Group, IAG, Keller Group Aug 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral Group, IAG and Keller Group, on Wednesday. HIGHLIGHTS * Admiral Group Plc ADML.L : HSBC raises target price to 2700p from 2625p * IAG ICAG.L : Citigroup raises target price to 245p from 225p * Keller Group Plc KLR.L : Deutsche Bank raises target price to 1800p from 1550p * OCI NV OCI.AS : JP Morgan raises to overw
A
A
A
B
B
B
B
G
H
I
K
L
M
R
R
S
T
V
Q
M
R

Qiagen NV reports results for the quarter ended in June - Earnings Summary

Qiagen NV reports results for the quarter ended in June - Earnings Summary Qiagen NV QGEN.N reported quarterly adjusted earnings of 55 cents​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of 53 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 51 cents per share.
Q

Qiagen Says FY Net Sales Are Expected To Be At Least $1.985 Billion CER

BRIEF-Qiagen Says FY Net Sales Are Expected To Be At Least $1.985 Billion CER July 31 (Reuters) - Qiagen NV QIA.DE : QIAGEN DELIVERS SOLID PERFORMANCE AND EXCEEDS OUTLOOK FOR Q2 2024 NET SALES WERE STABLE AT $496 MILLION IN Q2 2024 COMPARED TO Q2 2023 : HAS UPDATED ITS FY 2024 OUTLOOK FY OUTLOOK FOR ADJUSTED DILUTED EPS HAS BEEN INCREASED TO AT LEA
Q

Qiagen NV <QGEN.N> expected to post earnings of 51 cents a share - Earnings Preview

Qiagen NV expected to post earnings of 51 cents a share - Earnings Preview Qiagen NV QGEN.N , QGEN.K is expected to show a fall in quarterly revenue when it reports results on July 31 for the period ending June 30 2024 The Venlo Limburg-based company is expected to report a 0.1% decrease in revenue to $494.489 million from $494.86 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
Q

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead July 26 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 30-Jul-2024 NTS 1COV.DE Covestro AG Half Year 2024 Covestro AG Earnings Release 30-Jul-2024 BMO HEIG.DE Heidelberg Materials AG Half Year 2024 Heidelberg Materials AG Earnings Release 30-Jul-2024 04:30 AIR.PA Airbus SE Half Year 2024 Airbus SE Earnings Release 31-Jul-2024 AMC QGEN.N Qiagen NV Q2 20
A
A
B
F
M
P
S
S
V
V
Q
G



Condições

Ativos populares

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.